Cerroni L (March 2018). "Mycosis fungoides-clinical and histopathologic features, differential diagnosis, and treatment". Seminars in Cutaneous Medicine and Surgery. 37 (1): 2–10. doi:10.12788/j.sder.2018.002. PMID29719014.
Travaglino A, Russo D, Varricchio S, Pignatiello S, Baldo A, Picardi M, et al. (August 2021). "Prognostic Significance of CD30 in Transformed Mycosis Fungoides". American Journal of Clinical Pathology. 156 (3): 350–355. doi:10.1093/ajcp/aqaa261. PMID33769436.
Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C (February 2014). "Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions". Journal of the American Academy of Dermatology. 70 (2): 223.e1–223.e17. doi:10.1016/j.jaad.2013.08.033. PMID24438970.
Cerroni L (March 2018). "Mycosis fungoides-clinical and histopathologic features, differential diagnosis, and treatment". Seminars in Cutaneous Medicine and Surgery. 37 (1): 2–10. doi:10.12788/j.sder.2018.002. PMID29719014.
Vaidya T, Badri T (2021). "Mycosis Fungoides". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID30137856. Retrieved 2021-11-29.
Travaglino A, Russo D, Varricchio S, Pignatiello S, Baldo A, Picardi M, et al. (August 2021). "Prognostic Significance of CD30 in Transformed Mycosis Fungoides". American Journal of Clinical Pathology. 156 (3): 350–355. doi:10.1093/ajcp/aqaa261. PMID33769436.
Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C (February 2014). "Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions". Journal of the American Academy of Dermatology. 70 (2): 223.e1–223.e17. doi:10.1016/j.jaad.2013.08.033. PMID24438970.